Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 23.3B | 31.1B | 22.6B | 23.4B |
Cost of revenue | 18.5B | 24.0B | 17.4B | 16.9B |
Gross profit | 4.8B | 7.2B | 5.1B | 6.5B |
Operating expense | ||||
Research & development | 583.6M | 738.7M | 572.9M | 504.5M |
Selling general and admin | 3.6B | 5.3B | 3.8B | 4.0B |
Other operating expenses | — | — | — | — |
Operating income | 590.6M | 1.9B | 727.0M | 2.1B |
Non operating interest income | ||||
Income | 268.6M | 312.0M | 310.5M | 356.6M |
Expense | — | — | — | — |
Other income expense | 523.6M | -530.6M | 634.1M | 341.3M |
Pretax income | 1.4B | 1.6B | 1.7B | 2.7B |
Tax provision | 527.5M | 1.0B | 503.1M | 849.0M |
Net income | 855.3M | 577.2M | 1.2B | 1.9B |
Basic EPS | 0.8 | 0.5 | 1.1 | 1.7 |
Diluted EPS | 0.7 | 0.5 | 1.0 | 1.6 |
Basic average shares | 1.1B | 1.1B | 1.1B | 1.1B |
Diluted average shares | 1.2B | 1.2B | 1.2B | 1.2B |
EBITDA | 519.7M | 3.4B | 573.0M | 2.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | 444K | -7.3M | 2.7M | -8.3M |
Preferred stock dividends | — | — | — | — |